Interventions for ST Elevation Myocardial Infarction in Women
Vivian G Ng1, Alexandra J Lansky1
1Valve Program, Yale University School of Medicine, Yale University Medical Center, PO Box 208017, New Haven, CT 06520-8017, USA.
Interventional Cardiology Clinics
|June 6, 2017
Summary
Advances in ST-segment elevation myocardial infarction (STEMI) care improve outcomes, but women remain underrepresented in trials. This review examines STEMI treatments and outcomes specifically for women.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Medical Research
Background:
- ST-segment elevation myocardial infarction (STEMI) management has evolved with reperfusion therapies.
- Cardiovascular disease is a leading cause of death for both sexes.
- Women are underrepresented in STEMI clinical trials.
Purpose of the Study:
- To review STEMI treatment options.
- To analyze outcomes for women undergoing reperfusion therapy for STEMI.
- To highlight sex-based outcome disparities in STEMI.
Main Methods:
- Literature review of STEMI management strategies.
- Analysis of clinical trial data focusing on reperfusion therapies.
- Examination of studies comparing male and female STEMI patient outcomes.
Main Results:
- Reperfusion therapies (thrombolytics, percutaneous coronary revascularization) have improved STEMI outcomes.
- Studies indicate disparities in STEMI outcomes between men and women.
- Women's specific outcomes after reperfusion therapy require further investigation.
Conclusions:
- STEMI treatment has advanced significantly.
- Women experience different outcomes post-STEMI compared to men.
- Further research is needed to optimize STEMI care for women.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.7K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.8K
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
347
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
01:20Angina V: Nursing Management
428
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
428
01:30Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
01:26Angina IV: Management
366
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366
01:27Coronary Artery Disease V: Interprofessional Care
346
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
01:26Acute Coronary Syndrome V: Nursing Management
419
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
419